December 13, 2024 23:49 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bengaluru techie suicide: Karnataka Police issues summons to wife Nikita, her family members | French President Macron appoints centrist leader Francois Bayrou as new Prime Minister | Congress always prioritised personal interest over Constitution: Rajnath Singh | Jaishankar calls attack on Hindus in Bangladesh 'a source of concern' | Allu Arjun arrested over woman's death in stampede during Pushpa 2 premiere show | RBI receives bomb threat in Russian language, case filed | UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess
US phase 3 trial data shows 79% vaccine efficacy against symptomatic COVID-19: AstraZeneca

US phase 3 trial data shows 79% vaccine efficacy against symptomatic COVID-19: AstraZeneca

Mar 23, 2021, at 03:39 am

Ontario/IBNS: Advanced trial data from a US study on AstraZeneca coronavirus vaccine showed it is 79 per cent effective at preventing symptomatic COVID-19 and was 100 per cent effective in halting severe disease and hospitalization, said AstraZeneca in a statement on Monday.